Interestingly, when subdividing psoriasis patients based on disease severity, significant increases in IL-6 gene expression were observed in severe psoriasis and PsA subgroups, suggesting that elevated IL-6 expression in PBMCs may serve as a biomarker for the progression of psoriasis to arthropathic manifestations (37). This evidence concerns the gene IL6 and psoriasis.